
Biotechnology • Healthcare Insurance • Pharmaceuticals
CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative oncolytic immunotherapies for patients with bladder cancer. The company's primary investigational product, cretostimogene grenadenorepvec, aims to provide a bladder-sparing therapeutic option, enhancing the quality of life for afflicted patients. With ongoing clinical studies highlighting the potential benefits of their therapies, CG Oncology strives to address the unmet needs in bladder cancer treatment.
11 - 50 employees
Founded 2010
🧬 Biotechnology
⚕️ Healthcare Insurance
💊 Pharmaceuticals
💰 $120M Series E on 2022-11
2 days ago
Director responsible for omnichannel execution and engagement at CG Oncology. Bridging data, marketing, and IT to enable data-driven customer engagement.
🇺🇸 United States – Remote
💵 $183k - $215k / year
💰 $120M Series E on 2022-11
⏰ Full Time
🔴 Lead
👔 Director
October 2
Health Systems Director at CG Oncology, focusing on strategic account management in the biopharmaceutical industry. Engaging with key decision makers to enhance patient access and drive demand.
🇺🇸 United States – Remote
💵 $183k - $215k / year
💰 $120M Series E on 2022-11
⏰ Full Time
🔴 Lead
👔 Director